Crispr Therapeutics Stock Been: A Roller-Coaster Year Unpacked
CRISPR Therapeutics stock has zigzagged all year, driven by pipeline milestones, regulatory updates, and funding need...
Tax lots affect cost basis and gains in retirement accounts. This piece compares ETFs and mutual funds to help you choose.
25,093 articlesCRISPR Therapeutics stock has zigzagged all year, driven by pipeline milestones, regulatory updates, and funding need...
A troubling trend is rising where criminals recruit ordinary people through Telegram to intercept high-value deliveri...
Debt financing for AI infrastructure surged almost 100% over the last year, reshaping risk in credit markets. Analyst...
A US traveler finds herself stranded in Dubai as regional tensions flare after attacks tied to Iran. The story highli...
Billionaire investor Bill Ackman continues to chase value in everyday choices, even as his net worth sits among the u...
Investors are hoarding cash as volatility climbs and policy signals shift risk expectations. The dash cash only just ...
In a year of currency flux, veteran trader Scott Bessent's history of bold bets sheds light on Beijing's yuan policy ...
The Lego Foundation unveils a five-year, $97 million plan with the International Rescue Committee to bring play-based...
Tokenized treasuries moving onto the XRP Ledger are expanding rapidly, with massive on-chain volumes and a key JPMorg...
Investors weigh Pfizer's CFO transition as the broader market climbs. This look at the stock market today, june revea...
When a loved one appears on a jail roster, scam artists step in with urgent payment requests. Learn how to spot these...
Apple has chosen caution in the AI race, trading near its highs as investors bet on durability and profits over rapid...